Investigation of the treatment effect of Lansoprazole to sleep related GERD

Investigation of the treatment effect of Lansoprazole to sleep related GERD - Investigation of the treatment effect of Lansoprazole to sleep related GERD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008063

Enrollment

200

Registered

2012-05-31

Start date

2012-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep related gastroesophageal reflux disease

Interventions

sleep disturbance(+) sleep disturbance(-)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: sleep related Gastroesophageal Reflux Disease patients

Exclusion criteria

Exclusion criteria: .The patient who has an anamnesis of hypersensitivity to the ingredient of Lansoprazole .The patient who cannot take this agent properly .The patient who take atazanavir sulfate .The patient in whom oral administration is impossible .The patient with advanced respiratory-organs control .The patient who has taken the sleep introduction agent

Design outcomes

Primary

Measure	Time frame
.Improvement of the Pittsburgh sleep quality index. .Improvement of the Frequency Scale for the Symptoms of GERD	—

Secondary

Measure	Time frame
.Various physical findings .Various laboratory evidence .upper gastrointestional endoscopy .Health Related Quality of Life .Epworth sleepiness Scale .Beck Depression Inventory .Reflux Finding Score .pharyngeal obstruction	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026